Literature DB >> 7951327

The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene.

J Wu1, J R Forbes, H S Chen, D W Cox.   

Abstract

The Long-Evans Cinnamon (LEC) rat shows similarity to Wilson disease in many clinical and biochemical features. We have cloned cDNAs for the rat gene (Atp7b) homologous to the human Wilson disease gene (ATP7B) and have used them to identify a partial deletion in the Atp7b gene in the LEC rat. The deletion removes at least 900 bp of the coding region at the 3' end, includes the crucial ATP binding domain and extends downstream of the gene. Our results provide convincing evidence for defining the LEC rat as an animal model for Wilson disease. This model will be important for studying liver pathophysiology, for developing therapy for Wilson disease and for studying the pathway of copper transport and its possible interaction with other heavy metals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7951327     DOI: 10.1038/ng0894-541

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  61 in total

1.  Full-length cellular β-secretase has a trimeric subunit stoichiometry, and its sulfur-rich transmembrane interaction site modulates cytosolic copper compartmentalization.

Authors:  Filip Liebsch; Mark R P Aurousseau; Tobias Bethge; Hugo McGuire; Silvia Scolari; Andreas Herrmann; Rikard Blunck; Derek Bowie; Gerd Multhaup
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

2.  Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses.

Authors:  A B Shah; I Chernov; H T Zhang; B M Ross; K Das; S Lutsenko; E Parano; L Pavone; O Evgrafov; I A Ivanova-Smolenskaya; G Annerén; K Westermark; F H Urrutia; G K Penchaszadeh; I Sternlieb; I H Scheinberg; T C Gilliam; K Petrukhin
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

3.  Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper.

Authors:  G W Verhaegh; M J Richard; P Hainaut
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

4.  Consequences of copper accumulation in the livers of the Atp7b-/- (Wilson disease gene) knockout mice.

Authors:  Dominik Huster; Milton J Finegold; Clinton T Morgan; Jason L Burkhead; Randal Nixon; Scott M Vanderwerf; Conrad T Gilliam; Svetlana Lutsenko
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

5.  Copper and ceruloplasmin metabolism in the LEC rat, an animal model for Wilson disease.

Authors:  H Kodama; Y Murata; D Mochizuki; T Abe
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 6.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

7.  Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation.

Authors:  A S Payne; E J Kelly; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Enhanced Mn-SOD immunoreactivity in the dopaminergic neurons of long-evans cinnamon rats.

Authors:  Dong Woon Kim; Tae-Beom Ahn; Jong Min Kim; Gye Sun Jeon; Je Hoon Seo; Beom S Jeon; Sa Sun Cho
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

Review 9.  Copper transporting P-type ATPases and human disease.

Authors:  Diane W Cox; Steven D P Moore
Journal:  J Bioenerg Biomembr       Date:  2002-10       Impact factor: 2.945

10.  A novel rat model of hereditary hemochromatosis due to a mutation in transferrin receptor 2.

Authors:  Thomas B Bartnikas; Sheryl J Wildt; Amy E Wineinger; Klaus Schmitz-Abe; Kyriacos Markianos; Dale M Cooper; Mark D Fleming
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.